| Name | lymphocyte antigen 6 family member L |
| Description | Predicted to be located in side of membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n LY6L is a member of the LY6/urokinase‐type plasminogen activator receptor (uPAR) superfamily, a group of cysteine‐rich proteins unified by a distinctive “three‐finger” LU domain formed through a conserved disulfide bond pattern. Studies of LY6 family proteins show that, despite sharing this common tertiary structure, individual members can differ markedly in their subcellular localization and biological functions. For example, many proteins in this family are anchored to the cell membrane via GPI anchors or exist in secreted forms, implicating them in diverse cellular processes ranging from immune cell regulation to signal transduction and cell–cell communication."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " Although detailed characterization of LY6L specifically is still emerging, its genomic context within conserved syntenic regions on human chromosome 8 and the corresponding mouse chromosome indicates a preserved evolutionary role, which is often associated with critical functions in the modulation of immune responses and cellular adhesion."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Additionally, evidence from experimental disease models, such as hypoxic pulmonary hypertension, has identified differential expression of LY6L—along with related long noncoding RNAs—suggesting that LY6L may engage in post-transcriptional regulation as a competing endogenous RNA (ceRNA) that influences inflammatory and immune signalling pathways."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Furthermore, reports discussing related LY6 family antigens (e.g., the well‐known Stem Cell Antigen-1) support the view that these proteins are integral to cellular differentiation and immune modulation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " Taken together, while the precise mechanisms by which LY6L acts are not yet fully defined, current findings indicate that it likely plays an important role in both structural cell surface interactions and regulatory functions in health and disease.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Chelsea L Loughner, Elspeth A Bruford, Monica S McAndrews, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Organization, evolution and functions of the human and mouse Ly6/uPAR family genes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Genomics (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s40246-016-0074-2"}], "href": "https://doi.org/10.1186/s40246-016-0074-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27098205"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27098205"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Julie Maja Leth, Katrine Zinck Leth-Espensen, Kristian Kølby Kristensen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evolution and Medical Significance of LU Domain-Containing Proteins."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms20112760"}], "href": "https://doi.org/10.3390/ijms20112760"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31195646"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31195646"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Moriya Shmerling, Michael Chalik, Nechama I Smorodinsky, et al. "}, {"type": "b", "children": [{"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "LY6S,"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " a New IFN-Inducible Human Member of the Ly6a Subfamily Expressed by Spleen Cells and Associated with Inflammation and Viral Resistance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Immunohorizons (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/immunohorizons.2200018"}], "href": "https://doi.org/10.4049/immunohorizons.2200018"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35440514"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35440514"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Jie Liu, Yishu Deng, Zeqin Fan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Construction and analysis of the abnormal lncRNA-miRNA-mRNA network in hypoxic pulmonary hypertension."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biosci Rep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BSR20210021"}], "href": "https://doi.org/10.1042/BSR20210021"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34374413"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34374413"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Geeta Upadhyay "}, {"type": "b", "children": [{"type": "t", "text": "Emerging Role of Lymphocyte Antigen-6 Family of Genes in Cancer and Immune Cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Immunol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fimmu.2019.00819"}], "href": "https://doi.org/10.3389/fimmu.2019.00819"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31068932"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31068932"}]}]}]}
|
| NCBI Gene ID | 101928108 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
LY6L has 954 functional associations with biological entities spanning 5 categories (functional term, phrase or reference, disease, phenotype or trait, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 9 datasets.
Click the + buttons to view associations for LY6L from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of LY6L gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with LY6L protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with LY6L gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of LY6L gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of LY6L gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of LY6L gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of LY6L gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of LY6L gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with LY6L protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |